RediNews
ETFs Holding ACAD »    ACAD Historical Stock Prices »
ACAD News Video: Wed, Jan 4, 2017, 12:30 PM — Wednesday's ETF with Unusual Volume: FNX


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Acadia Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of medicines that address unmet medical needs in central nervous system disorders. Co.'s drug candidate includes NUPLAZID (pimavanserin), for which it has reported positive Phase III pivotal trial results in Parkinson's disease psychosis. Co. is in Phase II development with pimavanserin as a potential new treatment for Alzheimer's disease psychosis. Co. holds worldwide commercialization rights to pimavanserin. In collaboration with Allergan, Inc., Co. also discovered small molecule product candidates for the treatment of chronic pain. Self directed investors in Acadia Pharmaceuticals Inc will be interested in keeping up with all Acadia Pharmaceuticals Inc news they can find, both ACAD news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on ACAD. At RediNews, we simplify this task by presenting both ACAD news releases originating from Acadia Pharmaceuticals Inc itself, and ACAD news from a variety of media outlets. Visitors can browse this news online and through our ACAD RSS news feed.

ACAD News

ACAD News — Articles, Videos, & Press Releases

First Week of May 19th Options Trading For Acadia Pharmaceuticals (ACAD)
Wednesday, March 22, 2017, 11:42 AM — Stock Options Channel
Noteworthy ETF Outflows: XBI, CLVS, KITE, ACAD
Tuesday, March 21, 2017, 11:33 AM — ETF Channel
Barry Rosenstein Vs. The Shorts: Five Surprising Holdings
Friday, March 10, 2017, 1:23 PM — Dividend Channel
Analysts Expect BBH Will Reach $134
Thursday, March 2, 2017, 9:10 AM — ETF Channel
Noteworthy Wednesday Option Activity: RYN, VEEV, ACAD
Wednesday, March 1, 2017, 3:34 PM — Stock Options Channel
ACADIA Pharma (ACAD) Q4 Earnings: What's in Store this Time?
Thursday, February 23, 2017, 3:16 PM — Zacks
First Week of April 21st Options Trading For Acadia Pharmaceuticals
Wednesday, February 22, 2017, 11:45 AM — Stock Options Channel
FBT, ACAD, ALNY, KITE: ETF Outflow Alert
Tuesday, February 21, 2017, 10:57 AM — ETF Channel
5 Barry Rosenstein Holdings Attracting Short Sellers
Friday, February 10, 2017, 1:39 PM — Dividend Channel
Notable ETF Inflow Detected - XBI, CLVS, ACAD, UTHR
Thursday, February 2, 2017, 10:46 AM — ETF Channel
Acadia Pharmaceuticals (ACAD) Shares Cross Above 200 DMA
Thursday, January 26, 2017, 11:44 AM — Market News Video
Surprising Analyst 12-Month Target For FBT
Thursday, January 19, 2017, 9:38 AM — ETF Channel
SPDR S&P Biotech ETF Experiences Big Outflow
Thursday, January 5, 2017, 10:51 AM — ETF Channel
First Week of ACAD February 17th Options Trading
Thursday, January 5, 2017, 10:40 AM — Stock Options Channel
Noteworthy Wednesday Option Activity: GNMX, CSAL, ACAD
Wednesday, January 4, 2017, 3:28 PM — Stock Options Channel
Acadia Pharmaceuticals Breaks Above 200-Day Moving Average - Bullish for ACAD
Wednesday, January 4, 2017, 11:54 AM — Market News Video
Short Sellers Drawn To These Five Barry Rosenstein Holdings
Wednesday, December 28, 2016, 2:22 PM — Dividend Channel
ACADIA Phase II Alzheimer's Drug Hits Primary Endpoint
Wednesday, December 21, 2016, 9:07 AM — Zacks
Notable Tuesday Option Activity: LLNW, FRED, ACAD
Tuesday, December 20, 2016, 11:45 AM — Stock Options Channel
Analysts Expect VONG Will Reach $119
Thursday, December 15, 2016, 9:00 AM — ETF Channel
Notable Monday Option Activity: ZUMZ, LE, ACAD
Monday, December 12, 2016, 3:31 PM — Stock Options Channel
5 Barry Rosenstein Holdings Attracting Short Sellers
Monday, December 12, 2016, 2:02 PM — Dividend Channel
Noteworthy Monday Option Activity: TSLA, PXD, ACAD
Monday, December 5, 2016, 11:26 AM — Stock Options Channel
ACADIA Starts Phase II Schizophrenia Study on Pimavanserin
Wednesday, November 16, 2016, 8:16 AM — Zacks
ACAD Crosses Above Key Moving Average Level
Thursday, November 10, 2016, 1:45 PM — Market News Video
How The Parts Add Up: FNY Headed For $33
Thursday, November 10, 2016, 9:00 AM — ETF Channel
Investors Snag ACAD 15.2% Cheaper Than Its Secondary Stock Offering
Wednesday, November 9, 2016, 9:58 AM — Dividend Channel
Arena (ARNA) Q3 Earnings: Will the Stock Pull a Surprise?
Friday, November 4, 2016, 3:39 PM — Zacks
Will Kite Pharma (KITE) Stock Surprise Post Q3 Earnings?
Friday, November 4, 2016, 2:57 PM — Zacks
What to Expect from Repros (RPRX) This Earnings Season
Friday, November 4, 2016, 2:37 AM — Zacks
Puma Biotechnology (PBYI) Q3 Earnings: What's in Store?
Thursday, November 3, 2016, 4:24 PM — Zacks
ACADIA Pharma (ACAD): Will It Disappoint in Q3 Earnings?
Monday, October 31, 2016, 7:23 AM — Zacks
Acadia Pharmaceuticals Becomes Oversold
Thursday, October 27, 2016, 4:29 PM — Dividend Channel
First Week of June 2017 Options Trading For Acadia Pharmaceuticals (ACAD)
Tuesday, October 25, 2016, 10:39 AM — Stock Options Channel
Commit To Purchase Acadia Pharmaceuticals At $20, Earn 45.1% Annualized Using Options
Wednesday, October 19, 2016, 11:40 AM — Stock Options Channel
The Implied Analyst 12-Month Target For IWR
Monday, October 10, 2016, 9:23 AM — ETF Channel
Acadia Pharmaceuticals Enters Oversold Territory (ACAD)
Wednesday, October 5, 2016, 12:18 PM — Dividend Channel
Noteworthy Tuesday Option Activity: TITN, KRA, ACAD
Tuesday, October 4, 2016, 3:44 PM — Stock Options Channel
Notable Two Hundred Day Moving Average Cross - ACAD
Tuesday, October 4, 2016, 12:50 PM — Market News Video
Analysts See 19% Gains Ahead For FBT
Friday, September 9, 2016, 7:56 AM — ETF Channel
Investors Land ACAD 6.0% Cheaper Than Its Secondary Stock Offering
Thursday, August 11, 2016, 10:11 AM — Dividend Channel
Surprising Analyst 12-Month Target For FBT
Monday, August 8, 2016, 8:07 AM — ETF Channel
5 Drug Stocks to Watch for Earnings on Aug 4: BMRN & More
Wednesday, August 3, 2016, 7:36 AM — Zacks
ACADIA (ACAD) Q2 Earnings: What's in Store for the Stock?
Tuesday, August 2, 2016, 5:54 AM — Zacks
Acadia Pharmaceuticals Larger Than S&P 500 Component Discovery Communications
Monday, July 25, 2016, 4:38 PM — Market News Video
Commit To Buy Acadia Pharmaceuticals At $18, Earn 11.4% Using Options
Tuesday, July 19, 2016, 11:39 AM — Stock Options Channel
Analysts Forecast 12% Gains Ahead For IWF
Tuesday, July 5, 2016, 7:48 AM — ETF Channel
Noteworthy ETF Inflows: XBI, ACAD, ANAC, MDVN
Wednesday, June 15, 2016, 10:56 AM — ETF Channel
Noteworthy Monday Option Activity: EAT, ACAD, LNKD
Monday, June 6, 2016, 3:33 PM — Stock Options Channel
Notable ETF Inflow Detected - XBI, ACAD, ANAC, MDVN
Monday, June 6, 2016, 11:03 AM — ETF Channel
How The Parts Add Up: IYY Headed For $115
Tuesday, May 31, 2016, 7:58 AM — ETF Channel
XBI, ACAD, MDVN, ANAC: Large Inflows Detected at ETF
Thursday, May 26, 2016, 10:56 AM — ETF Channel
Bullish Two Hundred Day Moving Average Cross - ACAD
Tuesday, May 17, 2016, 11:32 AM — Market News Video
Notable ETF Outflow Detected - VTI, VIS, ACAD, CPHD
Wednesday, May 11, 2016, 10:58 AM — ETF Channel
Notable Monday Option Activity: ACAD, ECL, EXPD
Monday, May 2, 2016, 3:25 PM — Stock Options Channel
SPDR S&P Biotech ETF Experiences Big Outflow
Monday, May 2, 2016, 11:04 AM — ETF Channel
Surprising Analyst 12-Month Target For IYH
Wednesday, April 27, 2016, 7:37 AM — ETF Channel
VTI, VIS, ACAD, CPHD: Large Inflows Detected at ETF
Thursday, April 21, 2016, 11:18 AM — ETF Channel
First Week of December 16th Options Trading For Acadia Pharmaceuticals (ACAD)
Tuesday, April 19, 2016, 10:42 AM — Stock Options Channel
SPDR S&P Biotech ETF Experiences Big Inflow
Wednesday, April 13, 2016, 10:52 AM — ETF Channel
Investors Grab ACAD 47.8% Cheaper Than Its Secondary Stock Offering
Thursday, April 7, 2016, 11:20 AM — Dividend Channel
SPDR S&P Biotech ETF Experiences Big Outflow
Tuesday, April 5, 2016, 11:03 AM — ETF Channel
Why did Acadia Pharma (ACAD) Gained 17% on the Day?
Monday, March 28, 2016, 3:08 PM — Zacks
Notable Monday Option Activity: FB, ACAD, SGMS
Monday, March 28, 2016, 11:36 AM — Stock Options Channel
XBI, NVAX, ACAD, SGEN: ETF Inflow Alert
Monday, March 28, 2016, 11:10 AM — ETF Channel
First Week of ACAD May 20th Options Trading
Tuesday, March 22, 2016, 11:22 AM — Stock Options Channel
Notable Friday Option Activity: AIRM, ACAD, SYK
Friday, March 18, 2016, 3:28 PM — Stock Options Channel
Surprising Analyst 12-Month Target For IYH
Monday, March 7, 2016, 7:34 AM — ETF Channel
Acadia Pharmaceuticals Becomes Oversold (ACAD)
Friday, February 5, 2016, 4:31 PM — Dividend Channel
How The Pieces Add Up: IYH Targets $175
Thursday, February 4, 2016, 8:03 AM — ETF Channel
April 15th Options Now Available For Acadia Pharmaceuticals (ACAD)
Monday, January 25, 2016, 11:08 AM — Stock Options Channel
First Week of ACAD September 16th Options Trading
Friday, January 22, 2016, 11:29 AM — Stock Options Channel
Commit To Purchase Acadia Pharmaceuticals At $18, Earn 18% Annualized Using Options
Monday, January 11, 2016, 4:28 PM — Stock Options Channel
Investors Snag ACAD 52.5% Lower Than Its Secondary Stock Offering
Friday, January 8, 2016, 10:01 AM — Dividend Channel
Oversold Conditions For Acadia Pharmaceuticals (ACAD)
Wednesday, January 6, 2016, 4:31 PM — Dividend Channel
Interesting ACAD Put And Call Options For January 2018
Monday, November 16, 2015, 11:41 AM — Stock Options Channel
Noteworthy Monday Option Activity: LPLA, ACAD, ECOM
Monday, November 2, 2015, 3:22 PM — Stock Options Channel
First Week of ACAD June 2016 Options Trading
Wednesday, October 21, 2015, 11:51 AM — Stock Options Channel
Oversold Conditions For Acadia Pharmaceuticals (ACAD)
Monday, September 28, 2015, 4:49 PM — Dividend Channel
5 Sell-Ranked Biotechs That Fell More Than 5% Today
Friday, September 25, 2015, 3:53 PM — Zacks
Interesting ACAD Put And Call Options For November 20th
Thursday, September 24, 2015, 1:08 PM — Stock Options Channel
First Week of ACAD October 16th Options Trading
Friday, August 28, 2015, 11:33 AM — Stock Options Channel
Acadia Pharmaceuticals (ACAD) Shares Cross Below 200 DMA
Thursday, August 20, 2015, 4:52 PM — Market News Video
Acadia Pharmaceuticals Becomes Oversold (ACAD)
Friday, August 7, 2015, 12:07 PM — Dividend Channel
Commit To Buy Acadia Pharmaceuticals At $32, Earn 13.8% Using Options
Wednesday, July 22, 2015, 11:32 AM — Stock Options Channel
Notable ETF Outflow Detected - BIB, ACAD, XLRN, ACRX
Tuesday, July 21, 2015, 11:35 AM — ETF Channel
ProShares Ultra Nasdaq Biotechnology Experiences Big Outflow
Monday, June 22, 2015, 11:20 AM — ETF Channel
ProShares Ultra Nasdaq Biotechnology Experiences Big Outflow
Wednesday, June 10, 2015, 11:01 AM — ETF Channel
Notable ETF Outflow Detected - BIB, ACAD, XLRN, ACRX
Tuesday, June 2, 2015, 12:11 PM — ETF Channel
Acadia Pharmaceuticals Moves Up In Market Cap Rank, Passing QEP Resources
Monday, May 11, 2015, 4:37 PM — Market News Video
ProShares Ultra Nasdaq Biotechnology Experiences Big Inflow
Monday, May 4, 2015, 10:57 AM — ETF Channel
First Week of ACAD December 18th Options Trading
Wednesday, April 22, 2015, 11:22 AM — Stock Options Channel
BIB, ACAD, XLRN, ACRX: ETF Inflow Alert
Thursday, April 2, 2015, 11:02 AM — ETF Channel
First Week of May 15th Options Trading For Acadia Pharmaceuticals (ACAD)
Friday, March 27, 2015, 10:50 AM — Stock Options Channel
Will Epizyme (EPZM) Miss Estimates This Earnings Season? - Analyst Blog
Wednesday, February 25, 2015, 10:00 AM — Zacks
Myriad Genetics Q2 Earnings, Revenues Beat; Fall Y/Y - Analyst Blog
Wednesday, February 4, 2015, 8:58 AM — Zacks
Acadia Pharmaceuticals Larger Than S&P 500 Component Denbury Resources
Tuesday, February 3, 2015, 4:39 PM — Market News Video
First Week of September 18th Options Trading For Acadia Pharmaceuticals (ACAD)
Friday, January 23, 2015, 12:21 PM — Stock Options Channel
First Week of ACAD February 2015 Options Trading
Monday, December 29, 2014, 11:03 AM — Stock Options Channel
ProShares Ultra Nasdaq Biotechnology Experiences Big Outflow
Wednesday, December 3, 2014, 10:54 AM — ETF Channel
ProShares Ultra Nasdaq Biotechnology Experiences Big Inflow
Tuesday, November 25, 2014, 1:13 PM — ETF Channel
January 2017 Options Now Available For Acadia Pharmaceuticals (ACAD)
Monday, November 17, 2014, 11:46 AM — Stock Options Channel
Notable ETF Outflow Detected - BIB, ACAD, ACRX, ACHN
Monday, November 17, 2014, 11:32 AM — ETF Channel
First Week of June 2015 Options Trading For Acadia Pharmaceuticals (ACAD)
Thursday, October 23, 2014, 12:18 PM — Stock Options Channel
Noteworthy ETF Inflows: BIB, ACAD, ACRX, ACHN
Friday, August 22, 2014, 11:22 AM — ETF Channel
First Week of ACAD August 16th Options Trading
Tuesday, August 5, 2014, 11:40 AM — Stock Options Channel
Interesting ACAD Put And Call Options For March 2015
Tuesday, July 22, 2014, 11:55 AM — Stock Options Channel
ACAD Makes Bullish Cross Above Critical Moving Average
Tuesday, July 1, 2014, 12:07 PM — Market News Video
PowerShares DWA SmallCap Momentum Portfolio Experiences Big Outflow
Thursday, June 5, 2014, 10:55 AM — ETF Channel
Investors Grab ACAD 30.8% Cheaper Than Its Secondary Stock Offering
Wednesday, June 4, 2014, 1:26 PM — Dividend Channel
BIB, ACAD, ACRX, ACHN: ETF Outflow Alert
Wednesday, May 14, 2014, 10:53 AM — ETF Channel
Short Interest Jumps 10.8% For ACAD
Monday, May 12, 2014, 2:48 PM — Market News Video
DWAS, ACAD, MEIP, AXDX: Large Inflows Detected at ETF
Tuesday, May 6, 2014, 10:57 AM — ETF Channel
First Week of December 20th Options Trading For Acadia Pharmaceuticals Inc (ACAD)
Wednesday, April 23, 2014, 10:56 AM — Stock Options Channel
Acadia Pharmaceuticals Inc Enters Oversold Territory (ACAD)
Friday, April 11, 2014, 4:28 PM — Dividend Channel
Notable Two Hundred Day Moving Average Cross - ACAD
Tuesday, March 25, 2014, 4:32 PM — Market News Video
Investors Land ACAD Even Cheaper Than Its Secondary Stock Offering
Thursday, March 6, 2014, 11:27 AM — Dividend Channel
Notable ETF Inflow Detected - BIB, ACAD, ACRX, ACHN
Tuesday, February 25, 2014, 11:45 AM — ETF Channel
Commit To Purchase Acadia Pharmaceuticals At $15, Earn 17.9% Annualized Using Options
Wednesday, February 5, 2014, 12:00 PM — Stock Options Channel
BIB, ACAD, ACRX, ACHN: Large Inflows Detected at ETF
Friday, January 17, 2014, 10:48 AM — ETF Channel
Miss ACAD's $12.50 Offering But Think It's A Steal At $12?
Wednesday, October 9, 2013, 11:45 AM — Stock Options Channel
Miss ACAD's $12.50 Secondary But Think It's A Deal At $12?
Wednesday, September 4, 2013, 11:44 AM — Stock Options Channel
Miss ACAD's $12.50 Secondary But Think It's A Deal At $12?
Tuesday, August 6, 2013, 11:45 AM — Stock Options Channel
Miss ACAD's $12.50 Secondary But Think It's A Deal At $12?
Friday, July 5, 2013, 12:12 PM — Stock Options Channel
IWC, RDN, AEGR, ACAD: ETF Inflow Alert
Tuesday, June 25, 2013, 11:01 AM — ETF Channel
ACAD is categorized under the Healthcare sector; below are links to news for some other companies in the same sector:

GTIV News
BGMD News
CRIS News
MEIP News
LGND News
ARQL News
CRTX News
STAA News
BABY News
MDXG News

RediNews invites those seeking web page financial content for any internet portal, especially any vertical portal specializing in the markets where there is a web page for business, web page for markets, web page finance, etc., to integrate our free web site content, our RSS news feeds. These RSS feeds are found throughout our website wherever news and custom stock content is found, by clicking the RSS icon for any news page (which will look like this): . This dynamic financial content is ideal for sites that already feature stock data content such as historical stock price information whether in the form of a historical stock price table or a web page chart image, to supplement the other custom stock market content displayed.

ACAD News | www.RediNews.com | Copyright © 2013 - 2017, All Rights Reserved

Nothing in www.RediNews.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.